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Abstract 
Notwithstanding Nigeria’s large Muslim population of 89.25 million citizens, very little research has been 
carried out in terms of addressing Halal needs in Nigeria. This qualitative case study reviewed the 
perspective of 32 respondents, (15 patients, 15 doctors and two pharmacists), in a medical centre in 
Abuja, Nigeria on their perceptions on and awareness of Halal pharmaceuticals. The interview data were 
collected through telephone interviews. Data analysis and findings were examined against the literature 
reviewed in this study. Findings concluded that there was a lack of awareness of Halal medicine products 
within Nigeria and that this was the primary reason why the respondents felt that there was a dearth of 
Halal pharmaceuticals. There were also secondary concerns from the patients about the risk of counterfeit 
medicine and the doctors were worried at the potential cost of providing Halal pharmaceutical options in 
case it deterred patients from buying the (Halal) medicaments prescribed. The pharmacists were 
supportive of Halal pharmaceuticals in principle but highlighted issues surrounding both the efficacy of 
alternatives and the effectiveness of some current ingredients that might be deemed unacceptable in Halal 
preparations. 
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1. Introduction 
Nigeria is a country of over 178.5 million people (UNFPA, 2014) with over 250 ethnic groups, 36 federal 
states and the Federal Capital Territory (FCT), Abuja. Half of Nigeria’s population is Muslim (Pew 
Research Center 2010). Abuja is home to 2.8 million Muslims (National Bureau of Statistics, 2014). The 
Minister of Agriculture had galvanized Nigeria to expand its capacity in Halal products in order to satisfy 
the Halal needs (Adeshina, 2013). This supports the belief that Halal products are high in demand in 
Nigeria. Nigeria is currently bereft of an official Halal regulatory certifying organization for food or 
pharmaceuticals (Annabi & Lolade, 2015).  
The Halal pharmaceutical concept is relatively new to the global market (Siddiqui, 2014) which is 
hardly a surprise since the wider field of Halal logistics and supply chain management is still nascent 
(Tieman, 2013). According to the Global Islamic Economy Summit (2013) Halal has been primarily 
developed in three different categories: Halal Food, Halal Pharmaceuticals, and Halal Cosmetics. These 
are valued respectively at US$1,088 billion, US$70 billion, and US$26 billion. Although the former is the 
most widely known of the three concepts (Siddiqui, 2014) Halal pharmaceuticals are growing in 
recognition and the global Halal pharmaceutical industry is worth some US$800 billion annually (Nain et 
al., 2013). 
2. Literature Review 
2.1 The Difference between Halal and Haram 
“Halal” as an Arabic word coming from the Quran that means permitted, allowed, lawful or legal (Riaz 
& Chaudry, 2004). The opposite is haram which means unlawful, illegal or not allowed for a Muslim. 
Halal is usually applied to food, speech, conduct, dress and behaviour.  The most important principle with 
regards to Halal and haram is the permissibility of certain things whose right is with Allah alone (Al 
Qaradawi, 2007; Zakaria, 2008). Halalan tayyiban is a combination of lawfulness (Halalan), and goodness 
and safety (tayyiban). “Halalan tayyiban product means any products that are not harmful and safe to be 
consumed as underlined by the Sariah law, and   thus is allowable and permissible”   (Omar et al., 2013 
p. 3). It represents a concept of wholesomeness, which comprises quality, cleanliness and safety for all 
expected to eat from what is lawful and also to eat only what is good and safe for the body (Shah and 
Yusof, 2014) .  
For example, animals such as cows, goats and sheep, which are considered Halal, are expected to be 
slaughtered while mentioning the Tasmiyah (mentioning the name of Allah, i.e. Bismillahi, Allahu 
Akbar), and haram foods that should not be eaten include the flesh of an animal found dead, pork, swine 
flesh, predators, and any animal slaughtered while invoking a name other than Allah.  
“The Prophet Muhammad made lawful for consumption, two types of dead meat and two types of 
blood: Fish and Locust (dead meat), Liver and Spleen (blood)” (Surah al-Maidah, verse 53 from Al-
Qaradawi, 1999).  
“Makruh” or “karaha”, also written as makrouh/makrh/makrooh is an Arabic term which means to 
dislike or an offensive act and is the opposite of liked or loved. Though it is not haram (sinful), a person 
who abstains from this act will be rewarded. Muslims are encouraged to avoid such actions or foods as 
much as possible.  A makruh product is one that is of doubtable source. 
2.2 Implications for Halal Pharmaceuticals  in Nigeria 
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 Medicines are defined as a substance used to alleviate, nurse, cure or to prevent illness in humans or a 
substance used to promote better hygiene (Lokman, 2001). Medicine can be ingested, applied, injected or 
used internally through some other aperture (Lokman, 2001; Halim et al., 2014). Medicines that contain 
prohibited ingredients can be used only when there is no other alternative (Easterbrook & Maddern, 
2008).  
IbnQayyim (n/d) was the source of rationalisation by Zarif et al., (2013) for justification of the use of 
non-Halal medicine in permissible circumstances. Al-Asqalani (2000) called upon a tradition narrated by 
Anas ibn Malik where the Prophet Muhammad (PBUH) permitted the use of camel’s milk and urine to 
cure stomach sickness. This Hadith shows that in permissible circumstances impure things, (i.e. camel’s 
urine) are tolerated remedies for certain diseases; this could be compared with the case of intoxicants 
whereby the intoxicant is acceptable strictly for a particular circumstance. Al-Qaradawi (2007) suggested 
that haram products are potentially permissible in the event of certain conditions; the medicine 
containing alcohol is necessary for the life of the person who takes it, that it was recommended by a 
knowledgeable and trustworthy Muslim physician, and there were no Halal alternatives.  
There is some guidance in the Quran and Hadith that relate to the use of the word “khamr” 
(alcohol/intoxicant). Haleem (2005) offered a translation of the Quran where he argued that “khamr” has 
a combined connotation which encompasses all forms of intoxicants although the specific contexts in the 
Quran only referred to the consumption of alcohol. Ali (2104) has provided the following explanation: 
“Al-Tabari (d. 923) writes that “khamr” is every drink that intoxicates the mind, veils it, and covers it.  
It may be that during Muhammad’s time in Arabia, alcoholic beverages, such as khamr (wine made from 
grapes or dates), bit’ (wine from honey), and mizr (beer from barley), were the only available forms of 
intoxicants. There is no evidence of drug abuse resulting from recreational drug use, such as hemp 
(hashisha), henbane (banj) or opium (afyun), during the formative period of Islam. The Quran does not 
mention them nor were they a social problem, such that Muhammad had to give specific guidance about 
them” (p. 915). 
This will explain why at the time that the four scholars Hanafi, Maliki, Shafie and Hanbali were 
writing they hardly mentioned harmful drugs, owing mainly to the fact that such drugs were not in 
widespread use (Halim et al., 2014). It was only in 1983 that The Council of Rulers in Malaysia issued a 
Fatwa. This forbade misuse and the abuse of drugs with an endorsement that curative drugs can only be 
used as medicines in accordance with the Sharia (Taib, 1989). The new Malaysian Standard for Halal 
Pharmaceuticals (Department of Standards, 2012) required curative drugs to use ingredients that are 
accepted by Islamic law. In order to meet this standard only Halal substances should be used. The end 
products and all the materials used therein (e.g. packaging) must be free from “najis” (filth). This makes 
the medicine safe for human consumption. Safety in the Halal pharmaceutical context means that the 
medicine is non-hazardous, non-poisonous, and non-intoxicating to humans when consumed, injected or 
applied for the purpose of therapeutic curing or for healthy-living.  
Malaysia is the lead country in developing a global Halal certification standard, and Jabatan Kemajuan 
Islam Malaysia (JAKIM) is the body that authorizes the Halal integrity of products and associated Halal 
certifying organizations (HCOs) that issue the ensuing logo. The official portal for the Malaysian Halal 
Hub (2016) detailed 32 countries that have JAKIM recognized and affiliated HCOs. Nigeria does not 
have a globally authenticated HCO. Ironically countries with smaller Muslim populations such as 
Australia, Poland, Switzerland, the United Kingdom, and the United States of America are all listed 
which evidences that there has been consideration of religious needs where the Muslim demographic is 
relatively low unlike Nigeria, where 50% of the population, amounting to 89.25 million citizens, is 
Muslim. This perhaps introduces the idea of awareness and demand. 
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 There has been little demand for Halal pharmaceuticals in Nigeria. Despite the growing Muslim 
population, this populous has not widely demanded Halal products. Grabenstein (2013) reported that in 
Kano city, (in Nigeria’s Northwest region), polio vaccines were rejected due to the erroneous belief that 
these vaccines were infected with Human Immunodeficiency Virus (HIV). According to Alqudsi (2014), 
the lack of awareness of the importance of Halal products consequently reduces demand.  For example 
only recently have Muslim consumers voiced mandates for food and other non-food Halal services, such 
as financial instruments (Ismail, 2014). As the demand for Halal pharmaceuticals increases, the need for 
industries to be Halal certified will also increase (Shabana, 2013). Lada, et al., (2009) suggested that as 
Halal awareness grows then the concept and demand will expand beyond Halal food to encapsulate other 
markets.  
Malaysia is the global gold standard for Halal certification (Samori et al., 2014). The Malaysian Halal 
Standard offers an official standard on Halal pharmaceuticals through code MS 2424:2012, with products 
carrying a logo (Department of Standards, 2012). However there is not yet global recognition of this 
headway and even recent literature has suggested that this standardisation is still in development (e.g. 
Azeez et al., 2014).  Importantly, subscribing to a regulatory body to assure quality throughout the supply 
chain strengthens collaboration and helps build resilience into the continuity of supply (Tieman & 
Maznah, 2013).  
2.3 Research on Halal Pharmaceuticals 
Saleha et al. (2013) studied the perception, attitude, and knowledge of various medical practitioners. 
Their research concluded that many of the doctors were aware of the importance of patient knowledge as 
to whether or not a product was Halal and that the doctors from their study were in favour of appropriate 
“Halal” or “non-Halal” labelling for medicines.  
Fogel and Ebadi (2011) conducted a survey related to two vaccines used to prevent the human 
papillomavirus (HPV). The survey was carried out in different regions of India, which included a region 
with a high Muslim demographic. HPV is a sexually transmitted disease that can cause genital warts and 
the vaccines were created to prevent infection. Many Muslim parents refused to have their daughters 
vaccinated because they believed that that it might encourage promiscuity. Some of the Muslim parents 
also queried if the vaccine was derived from Halal sources.  
Daher et al. (2014) explored how often patients requested Halal pharmaceuticals from pharmacists in 
Australia. One major issue that pharmacists in Australia faced was the lack of proper packaging that 
suited the Muslim patients’ needs. This created challenges such as re-contacting the pharmaceutical 
industries to confirm the list of ingredients. Muslim patients were clearly uncomfortable as long as the 
source of an ingredient was non-Halal. When it was established that some of the tablet form medicine was 
non-Halal, most patients preferred to substitute the pills for medicine presented in syrups. 
2.4 Status of Ingredients in Medicine  
The manufacturers’ lists of ingredients on medicine packets tend not to be comprehensive. In order to 
be in accordance with Sharia law, all non-Halal animal derived ingredients should be replaced with Halal 
ingredients: These sources are the components that make the final products Halal or haram.  
An illustration of the hierarchy of Halal medicines where ethanol (alcohol) is used in the production is 
described in the following, adapted from Azeez et al. (2014): If the medicine is derived from active and 
inactive Halal sources then the final product is Halal. However, if ethanol is used in the preparation, then 
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 the final product would be makruh (doubtful).  What makes it doubtful is whether the ethanol evaporated 
during the process of heating or crystallization as there are scholars who might still agree it is Halal. 
However if the ethanol in the final product was in another non-solid form, then the Halal status of that 
medicine remains makruh. 
The use of alcoholic products as sources for medicines is still doubtful for producing Halal medicines 
(Nasaruddin et al., 2012). This rule applies to all unlawful ingredients used to produce the medicine. 
There are two main types of capsules used to produce medicines. The first is used for dry ingredients, and 
the second is the one used for liquid-like ingredients, such as primrose oil. These are both derived using 
gelatin. Gelatin can be derived either from plants (Halal) or from animals (haram). The haram source is 
used more frequently because it is less expensive than plant-based gelatin (Shah and Yusof, 2014). The 
risks involved in producing a certifiable Halal product involve strict monitoring of the entire process from 
the beginning of production to the point that the customer receives the product hand-in-hand. These 
processes include handling, packaging, storage, and transportation and therefore should be compliant with 
a Halal supply chain (Tiemen, 2013).  
Sources of ingredients like heparin, gelatin, ethanol, glycerin, glycerol and the enzyme trypsin are 
mostly non-Halal derived. Other ingredients like stearates, (magnesium, calcium and stearic acid) are 
generally sourced from lard or fatty acids from pigs’ stomachs and are used as lubricants and binders, 
although they can also be derived from vegetables (Shabana, 2013). Pharmaceutical ingredients such as 
gelatin have raised religious concerns due to its derivation from non-Halal animal products (Karim and 
Bhat, 2008). 
Alcohol is believed to be more harmful than useful in Islam. It was mentioned in a Hadith by the 
Prophet Muhammad (PBUH), “Khamr (Alcohol) is not a medicine, but a disease”. The Prophet 
Muhammad shed more light on the statement, saying, “Allah has sent down the disease and the cure, and 
for every disease, there is a cure. So take medicine, but do not use anything haram as medicine” (taken 
from Al-Qaradawi, 1999). Although in a later version of this scholar’s works it was suggested that haram 
products are potentially permissible if certain conditions exist  (Al-Qaradawi, 2007). 
2.5 Halal Certification in Nigeria (or the lack of it) 
Nigeria has one of the world’s largest Muslim population (O'Neil & Sachs, 2014). The country does 
not have Halal certification processes so is bereft of legal policies on Halal production. Nigeria practices 
some Halal concepts in the finance and banking field (Oshodi, 2014). Bello et al. (2013) commented that 
the term “Halal” was synonymous with animal slaughter in Nigeria. They also noted that major abattoirs 
failed to meet a minimum health and cleanliness standard and they attributed this failing to poor general 
hygiene, poor animal care, contaminated cross handling, and the lack of clean, chilled storage. Bonne and 
Verbeke (2008) also highlighted the absence of hygiene and stated that handling, preparing, storage, and 
transporting were of a dubious standard within the Nigerian beef cold chain. This implies that general 
hygiene processes are neglected. The interlinkage between preparation, handling, storage, and segregation 
from non-Halal sources and maintaining a robust supply chain was often overlooked in Nigerian Halal 
Beef production due to the lack of common standards or authentic governing agencies on all food 
production, rather than from a willful intent to mislead (Annabi & Lolade, 2015).  
The National Agency for Food and Drug Administration and Control (NAFDAC) attested that 
counterfeit medicines made in Nigeria was one of the galvanizing forces that led to the creation of its 
agency (NAFDAC, 2013). The World Health Organization (2014) has deemed counterfeit medicines as 
drugs that are purposely and fraudulently mislabelled, in order to mislead the identity or source of the 
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 medicine. NAFDAC is the only government food and drug administration in Nigeria. NAFDAC 
specializes in monitoring counterfeit medicines, the control of importation and exportation of medical 
devices, food and cosmetics, and the resultant distribution of these products (NAFDAC, 2013). In fact 
only recently NAFDAC recalled a dietary supplement because they discovered it contained undeclared 
ingredients like sibutramine, desmethylsibutramine, and phenolphthalein. These additions made the 
supplements unapproved drugs for which safety and efficacy had not been established. NAFDAC advised 
that these products were potentially life threatening if taken concomitantly with other medication 
(NAFDAC, 2016). This in itself was a positive step as previously Annabi and Lolade (2015) had reported 
that “Despite NAFDAC’s guidelines for controlling the country’s food industry, Nigeria is unwilling to 
enforce regulations; predominantly believed to be because of corrupt practices” (p. 4).   
Nigeria is included in the several assessments of international corruption (e.g. the World Bank’s 
Worldwide Governance Indicators, 2014; Transparency International’s Corruption Perception Index, 
2015). For example, in the Transparent International Report (2015) Nigeria ranks 136 from the 167 listed 
countries in relation to corrupt practices. 
 
2.6 Pull Strategies for Halal Products 
Push supply chains require the production of goods in advance, while pull supply chains mean the 
production of goods according to orders placed (Klass, 1998). Mazahir et al. (2011) list a benefit of the 
push strategy as the economies of scale it can master, but it suffers from an uncertainty in demand. 
Whereas a pull strategy responds to customer demands and can be adapted to control demand 
fluctuations, it faces costs concerns because it lacks economies of scale.  
3. Research Methodology 
Goddard and Melville (2004) defined research as the process of answering questions or seeking a non-
existent part of study, which adds to existing information. Kowalczyk (2014) stated that exploratory 
research is an investigation for something new. The purpose of this research is to explore the awareness 
of and perceptions on Halal pharmaceuticals in Nigeria by patients, doctors and pharmacist in a medical 
centre in Abuja. The research design used a case study approach, which focuses on the Halal concept. The 
single case study provides an opportunity to better understand but its limitations are that the results cannot 
be generalised.  
There are two main data collection techniques to be used in this research. They include the use of 
semi-structured interviews and a further ratification interview with one member from each group 
(patients, doctors and pharmacists). A semi-structured interview is usually an interview planned and 
arranged in advance, which involves open ended questions, and is the most widely used form of interview 
in a qualitative research (DiCicco-Bloom & Crabtree, 2006). Examples of the types of questions used  
were, “Explain the prescribing decisions you make with a patient”, “Do you consider the patients’’ 
religious background when prescribing and if so, what considerations are made?” and “As a patient, do 
you consider what ingredients are used in your medicines? If you do consider ingredients, how is that 
consideration expressed?” If prompting was required then the patient was further asked, “For example 
do you read the ingredients on the medicine packet, ask the doctor or consult with the pharmacist?” 
A semi-structured interview was believed to be appropriate for this research because it organized 
questions in such a way as to elicit meaningful answers for analysis. The semi-structured interviews were 
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 conducted by telephone as the researchers were resident within the United Arab Emirates. Whilst there 
are a number of limitations to a telephone interview there are also advantages. Bryman and Bell (2011) 
list these as low-cost, easy supervision (i.e. the ability to rephrase questions), less time-consuming, and 
less pressure on the interviewee due to physical absence of the interviewer. There was good reason to 
avoid the typical yes/no styled questions and that was based upon the issues reported by Maratsos and 
Kuczaj (1978), as cited by Hattori, (2003), who indicated that “doubling errors occur more frequently in 
contexts that cannot be simply characterized by the involvement of subject auxiliary inversion nor 
movement of a verbal element” (p. 2). They noted that it was not uncommon for interview subjects to use 
the incorrect verb form or apply past morpheme affixes redundantly for did-questions and does-questions, 
inserting a redundant auxiliary for repeated modal questions. Although the study by Maratos and Kuczaj 
(1978) involved children, Shin and Kellogg (2007) found that for English as a foreign language (EFL) 
speakers, early language development should be reconceptualised as language equivalent to primary 
school-level linguistics, hence the association as the respondents were not native speakers of  English. 
Guest et al. (2006) found that during an analysis of 60 qualitative interviews, saturation was achieved 
within 12 interviews, while initial meta-themes were found within just six interviews. As a result it was 
believed that 15 semi-structured interviews for both doctors and patients allowed for saturation and 
certainly this capacity was witnessed at respondent eight for the doctors, and at respondent seven for the 
patient group. All 32 respondents were Muslim.  
The questions were developed using the synthesis of themes raised in the literature review. The 
research sample size means that whilst findings cannot be generalized, larger samples can omit qualitative 
input (Bello et al., 2013). The interviewees were selected by the medical centre who had agreed to take 
part in the study and therefore the researchers were not directly involved in the selection criteria. This 
precludes researcher bias.  
Content analysis followed advice on the four phase approach by Jonker and Botma (2012) which 
firstly involved disassembling content by defining and categorising data into initial themes, e.g., by 
agreement or non-agreement. Secondly analysing these themes to reassemble an overview taking account 
of the themes and subthemes (e.g. being acquainted with Halal or haram concepts). The penultimate step 
called for discarding excess data such as general niceties and non-relevant chit-chat before the final phase 
that converts the language into codes that retain relevant participant extracts that validate narrative. This 
also allows for some direct quotes to enter the analysis to both emphasise and validate findings. Coding is 
qualitative research (Coffey et al., 1996).  
Onwuegbuzie et al. (2009) advised monitoring the thematic quantity and quality of words coming from 
each subgroup on themes and that this interest level could be used during codifying to gauge the 
importance of the topic under consideration. It was these themes and the initial findings that were further 
discussed with a random selection of one respondent each from the three respondent groups (patients, 
doctors and pharmacists). These three respondents took part in an unscripted telephone interview to 
establish consensus on whether the earlier compiled responses were deemed consistent with their general 
belief and subsequent informal discussions or reflections that they had since the semi-structured 
interviews. Research findings are reliable when similar conclusions are drawn from analyzing the data, 
which could be further tested by employing an additional research tool (Easterby-Smith, 2008).  
Issues surrounding ethical practices can skew attitudes (Miller et al., 2012) so this study adhered to 
ethical guidelines of the British Educational Research Association (BERA, 2011). 
4. Results and Data Analysis  
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 All the respondents were aware of the term Halal which is hardly surprising given that the medical 
centre was one that was favoured by Muslim patients and was predominantly employed Muslim staff. 14 
of the 15 patients, all 15 doctors and both of the pharmacists were also familiar with the concept of 
haram.  
This profile changed when respondents were asked if they were aware of Halal pharmaceuticals. Of 
the patient group only six of the 15 had heard the term and eight of the 15 doctors were conversant with 
the concept.  However both pharmacists were aware of Halal pharmaceuticals although that concurred 
that they had never been asked by patients for Halal medicines. 
When specifically asked if they were aware that some ingredients within some medicines were derived 
from haram sources such as animal-based gelatin, eight of the 15 patients, 14 of the 15 doctors and both 
pharmacists replied that they were conscious of this. The pharmacists disagreed as to whether 
manufacturers supplied accurate ingredient lists for their products. The pharmacist who said that there 
were not always an ingredients list mentioned that medicine in solid tablet form was often bereft of 
ingredient listing. Both pharmacists agreed that medicines in a syrup format came complete with an 
ingredients list. 
Only two of the 15 patients said that they requested Halal medicine from their doctors. All 15 doctors 
however claimed that they had never been asked by a patient to provide Halal only medicine when they 
prescribed. Interestingly, 10 of the 15 patients claim that doctors recommend Halal alternatives. 14 of the 
15 doctors agreed that they believed that their patients would be responsive to Halal alternatives but only 
two of the 15 said that they even made such suggestions. 
When respondents were asked to give two reasons why they thought Halal medicines were not readily 
available in Nigeria all 15 of the patients said because people were unaware of them. The other most 
favoured answer was because they perceived that Halal medicines would be at risk of being counterfeited 
(13 of the 15 patients).  The doctors all provided the same top reason, lack of awareness, for the absence 
of Halal medicines in country. However their second preferred reason, with 13 of the 15 expressing this, 
was that the Halal medicines might be more expensive and therefore less attractive for patients on an 
affordability basis and indeed may lead to patients deciding against purchasing their prescriptions. 
When asked if they would purchase Halal medicines in the event of their availability, nine of the 15 
patients said that yes they would buy these, even if these products were more expensive. This might allay 
the fears of the doctors’ who were concerned that patients would veto medicines that were too expensive 
(although there was still evidence of that with four of the 15 patients stating that they would be deterred 
by higher pricing). 12 of the 15 doctors believed that their patients would prefer to have Halal medicine if 
it was accessible. The pharmacists said that they would only offer Halal medicines to patients if there was 
a demand for Halal pharmaceuticals, meaning it was a “chicken and egg issue” according to one of the 
pharmacists.  As it stands currently though, the pharmacists “just provide them what is prescribed since 
there are no other options at this time”. The pharmacists said that they do not generally comment on 
pharmaceutical ingredients and only advise patients on how to take the medicine and if there is any 
requirement to mention concomitant medicine contraindications.  There was also an admission by one of 
the pharmacists that some non-halal ingredients such as alcohol actually serve as a preservative. 
Therefore without further review into alternative safer preservatives the pharmacist was quick to highlight 
that this was not an endorsement but merely an observation about its efficacy since it was the best option 
on offer at this time.   
5. Discussion 
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 With only six of the 15 patients knowing about Halal pharmaceuticals it clearly indicated that there 
was a lack of awareness of these products within the patient group. Although the numbers who were 
aware was increased to eight of the 15 doctors, this is just over half the group. Alqudsi (2014) suggested 
the lack of awareness of Halal products leads to a reduction in demand. Although neither of the 
pharmacists had ever been asked for Halal pharmaceuticals they were aware that often medicines with 
syrups were more likely to be Halal than those in solid tablet format. Equally only two from the patient 
group said that they had asked prescribing doctors for alternative Halal medicine, in contrast with all 15 
doctors claiming that they had never been asked by patients to prescribe medicine that met Halal criteria. 
Most of the doctors (14 of the 15) thought that their patients would be responsive to their suggested 
Halal alternatives which endorses the view of Lada, et al., (2009) who proposed a view that as Halal 
awareness grows, then the concept will expand beyond Halal food to encapsulate other markets; in this 
case pharmaceuticals. 
It is worth highlighting the fact that all the respondents believed that it was a lack of awareness that 
thwarted Halal pharmaceuticals from being available in Nigeria. It is evident that the fear of counterfeit 
medicine was also a significant concern and this reason was provided as the second cause for the lack of 
Halal pharmaceuticals from the patient group. It also indicates that obtaining bona fide sources of Halal 
medicine would be paramount. Shabana (2013) claimed that as Halal awareness increases the need for 
industries to be Halal certified will also increase. The lack of HCOs in Nigeria (Adesina, 2013; Annabi & 
Lolade, 2015) and the evidence of counterfeit medicine (NAFDAC, 2016) are two themes that would 
need addressed simultaneously to assure Halal pharmaceutical integrity. Perhaps at the most fundamental 
level though it is the perception of corruption that has to be tackled first as without trust in robust 
practices it would be impossible to have confidence in a reliable supply chain. Tiemen and Maznah 
(2013) emphasised the importance of regulatory bodies as a quality assurance mechanism for 
manufacturers and suppliers within the supply chain. Whilst supply chain ethos was not part of the main 
discussions with respondents, the attributes of the Halal supply chain would, in turn, enhance the 
capabilities of the pharmaceutical supply chain. Annabi and Lolade (2015) have demonstrated that Halal 
supply chain characteristics within Nigeria are nascent and therefore this presents an opportunity for 
either the government to take a lead or for the private sector to seek voluntary accreditation by developing 
associations through JAKIM. 
The pharmacists recognized that medicines in their current format were stabilized by ingredients that 
had “makruh” status at best, possibly “haram” status at worst, which is consistent with Azeez et al. 
(2014). This also echoed the belief that medicines that contain prohibited ingredients can be used in the 
absence of Halal alternatives (Easterbrook & Maddern, 2008; Al-Qaradawi 2007). The pharmacists were 
aware that they could suggest alternatives in the form of syrup-based medicines, (where they existed), in 
the event that a patient specifically asked for a medicine that was less likely to have “haram” ingredients. 
This is consistent with the findings of Daher et al. (2014). However the lack of labelling detailing the 
ingredients would need to be addressed in to ensure a transparency regarding the contents of both syrup 
and solid medicines. NAFDAC already have guidelines for registration of imported drug products in 
Nigeria under directive NAFDAC/RR/002/00 and for registration of drugs and related products 
manufactured in Nigeria under NAFDAC/RR/003/00. Both of these policies call for “Quantitative listing 
of all the active ingredients per unit dose” (NAFDAC/RR/002/00 n/d p. 2; NAFDAC/RR/003/00 n/d p.3). 
However given the comments from the pharmacists interviewed, it would appear that these procedures are 
not enforced, particularly in the case of tablet based medicines. Enforcement of these NAFDAC 
guidelines is recommended as a first step with the pharmaceutical packaging also being included in the 
guidelines for any Halal standard that emerges in order to preserve integrity.  
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 6. Conclusion 
There is a lack of awareness of Halal pharmaceuticals in general and it is not an issue that is isolated to 
Nigeria. Previous research has highlighted this and has linked lack of awareness to lack of demand. 
Therefore increasing awareness in Nigeria should lead to an increment in pull strategies whereby patients, 
doctors and pharmacists are respectively requesting, prescribing and procuring Halal pharmaceutical 
products. However the demand itself would not negate the requirement for a robust Halal Pharmaceutical 
standard especially in a country where fears and practice indicate that counterfeit products are more than 
merely a risk to Halal integrity, rather they could be life threatening to those who consume them.  
NAFDAC has the legitimacy to begin to enforce pharmaceutical labelling. In the short-term adopting 
pharmaceutical labelling for all medicines (both syrup and solid) would help support awareness of current 
practices and potentially help work towards adopting alternative Halal sources where they easily are 
available; i.e. using plant based gelatin as opposed to that from non-attested animal sources. However it is 
important to have a baseline to work from. 
This does not detract from the larger issue of contemplating how a Halal supply chain can be 
supported in Nigeria and it is for those involved to decide whether this should begin as a voluntary code 
or be one that is regulated from the outset: Only relevant stakeholders and shareholders can agree how it 
is interpreted, planned, initiated, adopted, implemented and sustained.  
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